INOVIO Pharmaceuticals, Inc.

INOVIO Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing innovative DNA medicines to combat HPV-related diseases, cancer, and infectious diseases. Utilizing proprietary technology, INOVIO designs optimized plasmids that instruct the body to produce disease-fighting proteins. Their investigational CELLECTRA® devices enhance the delivery of these plasmids without the use of chemical adjuvants, lipid nanoparticles, or viral vectors, aiming to transform treatment paradigms and improve patient outcomes through next-generation therapies.